RAB27A and prostate carcinoma: More importantly, the prostate cancer cells were also unable to grow in mice when Rab27a or aSNase2 was deleted by the CRISPR/Cas9 technique, leading to a blockade of exosome biogenesis (Poggio et al., 2019).